EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Limosilactobacillus reuteri supernatant attenuates inflammatory responses of human gingival fibroblasts to LPS but not to elevated glucose levels

T M Janson iD, L L Ramenzoni iD, C R Hatz iD, U Schlagenhauf, T Attin iD, P R Schmidlin iD

Journal of Periodontal Research · 2024

DOI: 10.1111/jre.13290 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Periodontal Research, 2024. Verfasst von T M Janson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Periodontology and Peri-implant Diseases, Clinic of Conservative and Preventive Dentistry, Center for Dental Medicine, University of Zuri…. Hauptthemen laut MEDLINE: Fibroblasts, Lipopolysaccharides, Gingiva, Glucose. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Streuli Pharma AG (Streuli Pharma AG, Uznach, Switzerland), Division of Periodontology and Peri-implant Diseases, Clinic of Conservative and Preventive Dentistry, Center for Dental Medicine, University of Zurich, Zurich….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

We investigated the in vitro effect of Limosilactobacillus reuteri DSM 17938 supernatant on the inflammatory response of human gingival fibroblasts (HGF) challenged by lipopolysaccharide (LPS) or elevated glucose levels.

Methods

HGF were exposed to LPS (1 μg/mL), glucose (5, 12 mM or 25 mM), and dilutions of supernatant prepared from L. reuteri DSM 17938 (0.5 × 10 7 , 1.0 × 10 7 , 2.5 × 10 7 , and 5.0 × 10 7 CFU/mL). After 24 h cell viability and levels of cytokines ( IL‐1β , IL‐6 and IL‐8 ) and TLR‐2 were determined.

Results

None of the tested L. reuteri (DSM 17938) supernatant concentrations reduced the viability of HGF. Supernatant concentrations (2.5 × 10 7 and 5 × 10 7 CFU/mL) significantly ( p < .05) decreased the production of IL‐1β , IL‐6 , IL‐8 , and TLR‐ 2 in the presence of LPS. In contrast, inflammatory markers were not reduced by L. reuteri supernatant in the presence of glucose. Glucose concentrations of 12 mM and 24 mM still lead to an elevated production of the investigated biochemical mediators.

Conclusion

While L. reuteri (DSM 17938) supernatant attenuates the inflammatory response of HGF to LPS in a dose‐dependent manner, elevated glucose levels suppress this action. These in vitro results support the overall anti‐inflammatory efficacy of L. reuteri supplementation in plaque‐associated periodontal inflammations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibroblastsLipopolysaccharidesGingivaGlucoseLimosilactobacillus reuteriHumansCytokinesCell SurvivalToll-Like Receptor 2Cells, CulturedInterleukin-8Interleukin-6Inflammation

Stichwörter der Autor:innen

Limosilactobacillus reuterihuman gingival fibroblastshyperglycemialipopolysaccharideprobiotics

Substanzen

LipopolysaccharidesGlucoseCytokinesToll-Like Receptor 2Interleukin-8Interleukin-6TLR2 protein, human

Autor:innen und Institutionen

  • Division of Periodontology and Peri-implant Diseases, Clinic of Conservative and Preventive Dentistry, Center for Dental Medicine, University of Zurich, Zurich, Switzerland.
  • Department of Conservative Dentistry and Periodontology, Center for Oral Health, University Hospital Wuerzburg, Wuerzburg, Germany.

ORCID-Profile: T M Janson, L L Ramenzoni, C R Hatz, T Attin, P R Schmidlin

Förderung

  • Streuli Pharma AG (Streuli Pharma AG, Uznach, Switzerland)
  • Division of Periodontology and Peri-implant Diseases, Clinic of Conservative and Preventive Dentistry, Center for Dental Medicine, University of Zurich, Zurich…

Zitieren

APA

Janson, T. M., Ramenzoni, L. L., Hatz, C. R., Schlagenhauf, U., Attin, T., & Schmidlin, P. R. (2024). Limosilactobacillus reuteri supernatant attenuates inflammatory responses of human gingival fibroblasts to LPS but not to elevated glucose levels. Journal of Periodontal Research. https://doi.org/10.1111/jre.13290

Vancouver

Janson TM, Ramenzoni LL, Hatz CR, Schlagenhauf U, Attin T, Schmidlin PR. Limosilactobacillus reuteri supernatant attenuates inflammatory responses of human gingival fibroblasts to LPS but not to elevated glucose levels. Journal of Periodontal Research. 2024. doi:10.1111/jre.13290

BibTeX
@article{Janson2024,
  author = {Janson, T M and Ramenzoni, L L and Hatz, C R and Schlagenhauf, U and Attin, T and Schmidlin, P R},
  title = {Limosilactobacillus reuteri supernatant attenuates inflammatory responses of human gingival fibroblasts to LPS but not to elevated glucose levels},
  journal = {Journal of Periodontal Research},
  year = {2024},
  doi = {10.1111/jre.13290}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche